Australia’s Sirtex Medical said Chinese fund manager CDH Investments has made an A$1.87 billion ($1.41 billion) offer for the liver-cancer treatment specialist, trumping an earlier offer by U.S. based Varian Medical Systems.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
